Skip to content

Clinical trials

Observational Coronary Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Disease Phase: Observational Clear all

650 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200012
200111
20027
200324
200414
200516
200616
200717
200815
200917
201031
20118
201233
201321
201417
201524
201625
201729
201818
201912
202014
202122
202221
202313
202417
202519
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed427
Unknown status114
Recruiting35
Active, not recruiting28
Withdrawn15
Not yet recruiting13
Terminated13
Enrolling by invitation4
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)142
Abbott Medical Devices14
CardioDx12
China National Center for Cardiovascular Diseases11
China Academy of Chinese Medical Sciences10
AstraZeneca8
University of Minnesota8
University of Toronto8
University College, London7
University of Washington6

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Disease650
Cardiovascular Diseases298
Heart Diseases232
Coronary Artery Disease126
Myocardial Infarction87
Stroke76
Atherosclerosis71
Hypertension71
Diabetes Mellitus66
Myocardial Ischemia62

Trials

Showing 26 to 50 of 650. Each trial links to its page on Pharma Observatory.

550 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.